Abstract

BackgroundSystemic sclerosis (SSc) is a connective tissue disorder characterized by microangiopathy, autoimmunity and fibrosis. Capillaroscopy is a simple method for direct observation of microvasculature. The pulse oximeter is a noninvasive...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Correlation between bone quality and microvascular damage in systemic sclerosis patients.
Vanessa Smith ... Giulia Botticella
Rheumatology (Oxford, England) | VOL. 57
Vanessa Smith, et. al.Vanessa Smith ... Giulia Botticella
18 May 2018
Effect of capillaroscopic patterns on the pulse oximetry measurements in systemic sclerosis patients
Sule Apras Bilgen ... Insan Ertenli
Microvascular Research | VOL. 98
Sule Apras Bilgen, et. al.Sule Apras Bilgen ... Insan Ertenli
14 Feb 2014
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY?
D Melchiorre ... G Ghezzi
-
D Melchiorre, et. al.D Melchiorre ... G Ghezzi
30 May 2023
Capillaroscopic pattern in systemic lupus erythematosus and undifferentiated connective tissue disease: What we still have to learn?
Ulf Müller-Ladner ... Sevdalina Nikolova Lambova
Rheumatology International | VOL. 33
Ulf Müller-Ladner, et. al.Ulf Müller-Ladner ... Sevdalina Nikolova Lambova
24 Apr 2012
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers